510(k) Report

510(k) · Cleared

Cleared

BD 1ml Luer-lok Hypodermic Syringe, BD 1 mL Luer-Lok Hypodermic Syringe with BD Hypodermic Needle or BD Eclipse Hypodermic Needle, BD 1ml Luer-lok Insulin Syringe

K162081510(k) TraditionalCleared Dec 19, 2016145-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson and Company · FMF Syringe, Piston

Cleared on Dec 19, 2016 as substantially equivalent to K941562 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 1994) and 3 other predicates after a 145-day review. Its family tree reaches back 2 generations to 1993. 1 later device descends from it.

Decided
Dec 19, 2016
Review
145 days
Class
Class II
Product code
FMF
Recalls
None
Predicates
4

Its longest line of descent runs back 2 generations to K931367 (1993). 14 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2016: 1 other ancestor2003: 1 other ancestor1994: 2 other ancestors2002: 1 other ancestor2001: 1 other ancestor2000: 1 other ancestor1997: 3 other ancestors1996: 1 other ancestor1995: 1 other ancestor2023: 1 descendant clearedK931367 · Vacutainer Brand Luer Adapter · Bd Becton Dickinson Vacutainer Systems Preanalytic · 1993K021475 · BD Single Lumen Needle, Syringe and Blood Collection Set · Bd · 2002 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 3 other ancestors2 generations back: 9 other ancestors 1 generation forward: 1 descendant K021475 · BD Single Lumen Needle, Syringe and Blood Collection Set · Bd · 2002 · recalledK931367 · Vacutainer Brand Luer Adapter · Bd Becton Dickinson Vacutainer Systems Preanalytic · 19930
  1. Root · 2 generations backK931367 Vacutainer Brand Luer AdapterBd Becton Dickinson Vacutainer Systems Preanalytic · 1993
  2. 1 generation backK021475 BD Single Lumen Needle, Syringe and Blood Collection SetBd · 2002 · Recalled
  3. This deviceK162081 BD 1ml Luer-lok Hypodermic Syringe, BD 1 mL Luer-Lok Hypodermic…Becton, Dickinson and Company · 2016
  4. Descendant · cites it directly · 0 of its ownK222852 Nipro SafeTouch Needle; Nipro Syringe with SafeTouch NeedleNipro Medical Corporation · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K222852Nipro SafeTouch Needle; Nipro Syringe with SafeTouch NeedleNipro Medical Corporation · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K931367Vacutainer Brand Luer AdapterBd Becton Dickinson Vacutainer Systems Preanalytic1993—
−1K021475BD Single Lumen Needle, Syringe and Blood Collection SetBd20023
0 (this device)K162081BD 1ml Luer-lok Hypodermic Syringe, BD 1 mL Luer-Lok Hypodermic Syringe with…Becton, Dickinson and Company2016—
+1K222852Nipro SafeTouch Needle; Nipro Syringe with SafeTouch NeedleNipro Medical Corporation2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199510
199610
199730
200010
200110
200210
200310
201610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K162081, 1993–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMF device

  1. #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.1 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K9415621ML Luer-Lok Syringe
Summary page 6
…ode: FMF (Syringe, Piston) Predicate Devices: Trade Name: BD 1mL Luer-Lok™ Hypodermic Syringe 510(k) Reference: K941562 Common Name: Piston Syringe Classification: Class II device, 21…
Bd Becton Dickinson Vacutainer Systems Preanalytic1994—
*K021475BD Single Lumen Needle, Syringe and Blood Collection Set
Summary page 6
…Product Code: FMF (Syringe, Piston) Trade Name: BD Hypodermic Needle 510(k) Reference: K021475 Common Name: Hypodermic Needle Classification: Class II, 21 CFR…
Bd20023
*K161170BD Eclipse Hypodermic Needle
Summary page 6
…FMI (Needle, Hypodermic, Single Lumen) Trade Name: BD Eclipse™ Hypodermic Needle 510(k) Reference: K161170 Common Name: Hypodermic Needle Classification: Class II, 21 CFR…
Becton, Dickinson and Company20161
*K024112BD Insulin Syringe
Summary page 7
…n) Trade Name: BD 1mL Luer-Lok™ Insulin Syringe 510(k) Reference: K024112 Common Name: Piston Syringe Classification:…
Becton, Dickinson & CO20033

Also cleared against K941562: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K222852Nipro SafeTouch Needle; Nipro Syringe with SafeTouch NeedleNipro Medical Corporation20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 14.4 years on median.
  • 5 of the 14 ancestors have a recall of any class.
  • Of its descendants, K222852 (Nipro Medical Corporation, 2023) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K941562.

How does its category compare?

All FMF devices

FMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · FMF

13in 2025

2007: 232008: 92009: 142010: 112011: 162012: 92013: 122014: 132015: 112016: 122017: 132018: 82019: 112020: 152021: 202022: 242023: 222024: 142025: 132026 (partial year): 9
2007high 24 (2022) · low 8 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMF

114in 2025

2007: 90 days median2008: 74 days median2009: 94 days median2010: 130 days median2011: 109 days median2012: 86 days median2013: 154 days median2014: 84 days median2015: 87 days median2016: 146 days median2017: 135 days median2018: 87 days median2019: 146 days median2020: 107 days median2021: 175 days median2022: 211 days median2023: 173 days median2024: 130 days median2025: 114 days median2026 (partial year): 239 days median
2007high 239 (2026) · low 74 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMF

19in 2023

2007: 62008: 112009: 152010: 122011: 32012: 62013: 12014: 12015: 22017: 32018: 22019: 12020: 22021: 12022: 22023: 19, 18 Class I2026 (partial year): 2, 1 Class I
2007high 19 (2023) · low 0 (2016)2026

Class I (19 since 2007) Class II/III not classified

Adverse event reports per year · FMF

4,181in 2025

2007: 6742008: 6912009: 9132010: 6792011: 1862012: 3072013: 3262014: 2442015: 2732016: 6842017: 1,8582018: 3,9522019: 5,8632020: 5,3342021: 5,8742022: 5,2332023: 5,2142024: 5,1222025: 4,181
2007high 5,874 (2021) · low 186 (2011)2025

MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200723906674
200897411691
2009149415913
20101113012679
2011161093186
20129866307
2013121541326
201413841244
201511872273
2016121460684
20171313531,858
201888723,952
20191114615,863
20201510725,334
20212017515,874
20222421125,233
20232217319 (18)5,214
20241413005,122
20251311404,181
202692392 (1)—

What is it indicated for?

The BD 1mL Luer-Lok™ Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection. The BD 1mL Luer-Lok™ Hypodermic Syringe with BD Hypodermic Needle or BD Eclipse™ Hypodermic Needle is intended for use by health care professionals for general purpose injection and aspiration of fluid from vials, ampoules and parts of the body below the surface of the skin. The BD Eclipse™ Hypodermic Needle contains a…

Read the full statement (114 words)

The BD 1mL Luer-Lok™ Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection.

The BD 1mL Luer-Lok™ Hypodermic Syringe with BD Hypodermic Needle or BD Eclipse™ Hypodermic Needle is intended for use by health care professionals for general purpose injection and aspiration of fluid from vials, ampoules and parts of the body below the surface of the skin.

The BD Eclipse™ Hypodermic Needle contains a mechanism that covers the needlepoint after use. In the activated position the needle cover guards against accidental needle sticks during normal handling and disposal of the used needle/syringe combination.

The BD 1mL Luer-Lok™ Insulin Syringe is intended for subcutaneous injection of U-100 insulin.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K162081: BD 1ml Luer-lok Hypodermic Syringe, BD 1 mL Luer-Lok Hypodermic Syringe with BD Hypodermic Needle or BD Eclipse Hypodermic Needle, BD 1ml Luer-lok Insulin Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162081

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026